Industry Watch
•  Australian Cancer Technology Acquires US CancerCare Business
•  Premier to Accelerate Technology CommercializationFollowing Trial Success
•  Starpharma's Anti-STDs Lead ¾ VivaGelTM EntersHuman Clinical Trial
•  Epitan's MelanotanÒ Commences Human Implant Trial
•  Sinopharm Group Pharmaceutical Co. Established
•  Swedish Company Perbio Science Sets up Headquarters in Hong Kong
•  Zydus-Cadila Acquires Alpharma's French Business
•  Virionyx Collaborates with US Organizations to Develop SARS Treatment
•  AgResearch To Develop Potential GMO Vaccine for Tuberculosis
•  NUS Enterprise Reaps from Horseshoe Crab Research ¾ PryoGene

Products/Services Highlight
•  Rossmax Markets Blood Pressure Monitors in China
•  SARS Diagnostic Agent Developed

Research Findings
•  Doctors Grow In Vitro Embryonic Human Heart
•  Biodegradable Food Box and Plastic Sheet
•  Taiwanese Researchers Develop Low Cholesterol Eggs
•  Silkworms Potentially Valuable in Vaccine Development

Rules & Regulations
•  SARS Prevention Imports Tariff Free in China
•  Japan Bans Medicines Containing PPA

Agriculture
•  Increased Collaboration among Indian Biotech Giants

General News
•  China's First Liver-Kidney Transplant Successful
•  China Approves Clinical Trials of IFN á-2b for SARS Prevention
•  Indian Firms Investing in Speciality Diagnostic Services
•  Japan to Transform Rice into Biodegradable Plastic
•  New Zealand Denies Possible Case of Mad Cow Disease
•  World Largest Health Survey
•  Local Fish Company Employs Biotech Solutions to Monopolize Market

Global Development
•  SFDA Approves Tumor Necrosis Therapy for Marketing in China
•  Agilent Collaborates with Battelle Memorial Institute in Artificial Neural Network Technology
•  IARC Monographs Program Finds Betel-Quid and Areca-Nut Chewing Carcinogenic to Humans

Conference Calendar